基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Patients with cirrhosis will gradually develop portal hypertension(PHT)and esophagogastric varices,and subsequently the more severe and often lethal complications such as bleeding esophageal varices,ascites,spontaneous bacterial peritonitis,renal dysfunction and hepatic encephalopathy.To date,there is still not any effective therapy for the prevention of the development these serious complications.The initial factor leading to PHT is an increase in hepatic resistance.Then,the increase in portal blood flow contributes to the maintenance and exacerbation of PHT,as well as the formation of esophagogastric varices and lethal complications.Increasing evidence shows that,enlarged spleen not only contributes to the increase in portal venous inflow,but also plays a contributory role in promoting almost all lethal complications of cirrhosis through its resulted hypersplenism together with other mechanisms.So,we hypothesize that prophylactic splenectomy may efficiently delay the progression of cirrhosis and improve life quality and long-term survival of patients with cirrhosis.
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Potential Value of Splenectomy for the Life Quality and Long-term Survival of Patients with Cirrhosis
来源期刊 抗癌研究 学科 医学
关键词 PATIENTS SURVIVAL PREVENTION
年,卷(期) kayj_2020,(5) 所属期刊栏目
研究方向 页码范围 13-16
页数 4页 分类号 R57
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2020(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
PATIENTS
SURVIVAL
PREVENTION
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
抗癌研究
双月刊
2208-3545
Level 1Level 10, 50
出版文献量(篇)
135
总下载数(次)
0
论文1v1指导